|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
ALR decreased the HMGB1/TLR4 signaling pathway in AP Mice.
|
29511434 |
2018 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our data support the hypothesis that miR-21 modulates the inflammatory response during acute pancreatitis through the upregulation of Pias3 and downregulation of Hmgb1.
|
30537729 |
2018 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
TNF-α, IL-6, IL-8, HMGB1 and Hsp70 during hospital admissions might serve to evaluate risk of death due to AP.
|
30947809 |
2018 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Compared with the AP group, the AP+PD98059+siRNA group had decreased expression of DUSP1 in tissues, whereas the AP+PD98059 group had decreased serum expression levels of TNF‑α, IL‑1β, IL‑6, HMGB1, S100A12 and amylase, lipase and urinary trypsinogen‑2.
|
29393354 |
2018 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose of this meta-analysis was to comprehensively investigate the correlation between high mobility group box 1 (HMGB1) and interleukin-6 (IL-6) in relation to acute pancreatitis.
|
28618057 |
2018 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Changes of Serum Procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High Mobility Group Protein-B1 (HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy (CRRT) and Its Clinical Significance.
|
30136704 |
2018 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Dexamethasone inhibits NF‑кBp65 and HMGB1 expression in the pancreas of rats with severe acute pancreatitis.
|
30365121 |
2018 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A positive temporal link exists between early TAP activity and late HMGB1 expression in AP, and EP inhibits HMGB1 release.
|
28894846 |
2017 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis.
|
28754974 |
2017 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Association between high mobility group box‑1 protein expression and cell death in acute pancreatitis.
|
28440506 |
2017 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data suggest that HMGB1 regionally secreted by macrophages mediates pancreatic pain by targeting RAGE and CXCL12/CXCR4 axis in the early stage of acute pancreatitis.
|
28755135 |
2017 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A complex study of the plasma levels of HMGB1, sRAGE and circulating DNA can be informative in evaluations of acute pancreatitis with different levels of severity.
|
19451748 |
2009 |